Roger K.C. Ngan

Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy

George Lau, Harry Yiu, Hoi-Ching Cheng et al. · Gastroenterology · 2003 · 459 citations · Full text

Preemptive Lamivudine Therapy, Viral Hepatitis, Hepatitis B Patients +7

Preliminary Results of a Randomized Study on Therapeutic Gain by Concurrent Chemotherapy for Regionally-Advanced Nasopharyngeal Carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group

Anne W.M. Lee, W.H. Lau, Stewart Y. Tung et al. · Journal of Clinical Oncology · 2005 · 444 citations

Randomized Trial of Radiotherapy Plus Concurrent-Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma

A. W. M. Lee, Shui‐Yi Tung, Dtt Chua et al. · JNCI Journal of the National Cancer Institute · 2010 · 320 citations · Full text

Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial

Anthony T.�C. Chan, Edwin P. Hui, Roger K.C. Ngan et al. · Journal of Clinical Oncology · 2018 · 240 citations

Plasma Epstein-barr Virus, Medicine, Immunology +13

Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials

Anne W.M. Lee, Stewart Y. Tung, Roger K.C. Ngan et al. · European Journal of Cancer · 2010 · 218 citations

Concurrent–adjuvant Chemotherapy, Medicine, Advanced Nasopharyngeal Carcinoma +9